Hyderabad: Viyash Scientific Ltd, a Hyderabad-based animal health player formerly known as Sequent Scientific Ltd, is acquiring a 100% stake in Italian company BioForLife Italia Srl for a cash consideration of around Rs 188 crore.
The company has signed a binding agreement, through its wholly owned subsidiary Alivira Animal Health Ltd, for the deal that is expected to close in the second quarter of financial year 2026-27.
The deal marks Viyash’s strategic entry into Italy, which is one of Europe’s five largest animal health markets and a fast-growing hub for companion animal care.
BioForLife develops, commercialises and distributes pet care products, with established positions in nutritional complements, pharmaceuticals and rapid diagnostic tests. The company is also building a presence in faster-growing specialties such as dermatology and ophthalmology.
The company said the acquisition strengthens Alivira’s European footprint, which has been expanding with acquisitions across Europe, Latin America and Asia over the past decade.
The move will also support Viyash’s push to capitalise on the expanding companion animal health generics opportunity.
Viyash said the deal will create a platform to introduce products from Alivira’s pipeline into Italy, while also enabling the expansion of BioForLife’s range into other Alivira markets across Europe, the Middle East, Asia and Latin America.
“This acquisition represents another important step in our strategy to build a leading global companion animal health business,” said Dr Haribabu Bodeputi, managing director and group CEO, Viyash Scientific, citing the combination of BioForLife’s commercial reach and Alivira’s product development capabilities.
The company said BioForLife’s executives will continue to run operations of the Italian company, whose front-end commercial organisation reaches more than 80% of veterinary clinics in Italy, providing broad customer access and relationships that can support future launches.
Italy’s companion animal segment has been growing rapidly, driven by higher pet ownership, increasing “pet humanisation” and rising spending on preventive and specialised veterinary care, Viyash said.
Swati Bharadwaj is a business journalist with 30 years of experie...
Read MoreSwati Bharadwaj is a business journalist with 30 years of experience covering a host of sectors – right from technology, GCCs, talent, cybersecurity, pharma & biotech, aerospace & defence, BFSI, gems & jewellery to automotive, hospitality, infrastructure, retail, among others. She has worked with TOI and ET across multiple cities such as Hyderabad, Bengaluru, Pune and Ahmedabad.
Read Less
Follow Us On Social Media